Q1 2025 Holdings
Filed 2025-05-15 | 69 holdings | $3.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Climb BIO Inc(CLYM) | COM | 28658R106 | $1.3M | 1,040,115 | 0.0% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $1.4M | 116,660 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $1.6M | 7,232,701 | 0.1% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $2.3M | 523,989 | 0.1% |
| Ikena Oncology Inc | COM | 45175G108 | $3.2M | 2,515,513 | 0.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $3.5M | 219,015 | 0.1% |
| Aligos Therapeutics Inc(ALGS) | COM NEW | 01626L204 | $3.7M | 444,110 | 0.1% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $4.2M | 3,283,783 | 0.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $4.5M | 7,419,355 | 0.1% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $4.6M | 457,556 | 0.1% |
| Inovio Pharmaceuticals Inc(INO) | COM SHS | 45773H409 | $5.1M | 3,119,162 | 0.2% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $5.7M | 3,262,564 | 0.2% |
| Xencor Inc(XNCR) | COM | 98401F105 | $5.8M | 549,439 | 0.2% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $5.9M | 9,722,254 | 0.2% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $6.2M | 315,765 | 0.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $6.5M | 767,016 | 0.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $6.9M | 859,876 | 0.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $7.3M | 5,399,681 | 0.2% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $7.3M | 6,011,380 | 0.2% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $9.7M | 1,529,987 | 0.3% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $9.7M | 1,518,182 | 0.3% |
| Septerna Inc(SEPN) | COM | 81734D104 | $11.1M | 1,912,929 | 0.4% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $12.9M | 3,442,833 | 0.4% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $14.1M | 2,299,567 | 0.5% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $14.6M | 2,500,000 | 0.5% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $14.8M | 1,444,709 | 0.5% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $15.2M | 874,614 | 0.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $15.4M | 5,576,558 | 0.5% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $16.2M | 2,038,845 | 0.5% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $18.6M | 741,068 | 0.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $19.4M | 254,751 | 0.6% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $20.4M | 4,557,575 | 0.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $20.9M | 2,000,000 | 0.7% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $22.1M | 2,000,000 | 0.7% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $22.3M | 3,018,935 | 0.7% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $22.4M | 3,579,209 | 0.7% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $24.8M | 1,401,938 | 0.8% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $25.3M | 8,859,648 | 0.8% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $26.1M | 2,000,000 | 0.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $27.7M | 17,849,482 | 0.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $28.3M | 750,000 | 0.9% |
| Metsera Inc | COM | 59267L107 | $29.8M | 1,094,408 | 1.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $30.8M | 1,400,000 | 1.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $33.6M | 1,000,000 | 1.1% |
| Amgen Inc(AMGN) | COM | 031162100 | $35.2M | 113,035 | 1.1% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $36.0M | 3,269,126 | 1.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $36.3M | 2,000,000 | 1.2% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $41.9M | 1,411,402 | 1.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $42.8M | 2,357,702 | 1.4% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $46.9M | 700,000 | 1.5% |